Evidence map›Paper›PMID 36092705›Full record

ArticleFrontiers in cell and developmental biology2022

Crosstalk between acetylation and the tyrosination/detyrosination cycle of α-tubulin in Alzheimer's disease.

José Martínez-Hernández, Julie Parato, Aditi Sharma, Jean-Marc Soleilhac, Xiaoyi Qu, Ellen Tein, Andrew Sproul, Annie Andrieux, Yves Goldberg, Marie-Jo Moutin and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Tubulin Acetylation: A Critical Regulator of Microtubule Function.Results and problems in cell differentiation · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

José Martínez-HernándezInserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, Université Grenoble Alpes, Grenoble, France.
Julie ParatoDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.
Aditi SharmaInserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, Université Grenoble Alpes, Grenoble, France.
Jean-Marc SoleilhacInserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, Université Grenoble Alpes, Grenoble, France.
Xiaoyi QuDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.
Ellen TeinTaub Institute for Research Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY, United States.
Andrew SproulDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.
Annie AndrieuxInserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, Université Grenoble Alpes, Grenoble, France.
Yves GoldbergInserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, Université Grenoble Alpes, Grenoble, France.
Marie-Jo MoutinInserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, Université Grenoble Alpes, Grenoble, France.
Francesca BartoliniDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.
Leticia PerisInserm, U1216, CEA, CNRS, Grenoble Institut Neurosciences, Université Grenoble Alpes, Grenoble, France.
Columbia University Irving Medical Center · USCentre National de la Recherche Scientifique · FRGrenoble Institute of Neurosciences · FRCEA Grenoble · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FREmpire State University · USInserm · FR

Funding

Pathogenic Roles for Microtubule Stabilization Pathways in Alzheimers diseaseR01AG050658 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Francesca Bartolini · 2016 to 2026
$3.5M
Pathogenic Roles for Microtubule Stabilization Pathways in Alzheimer's DiseaseR56AG050658 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BARTOLINI, FRANCESCA · 2021 to 2021
$755k
Pathogenic Role of D2 tubulin in Peripheral NeuropathyR21NS120076 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BARTOLINI, FRANCESCA · 2020 to 2020
$446k
Formin-mediated stabilization of dynamic microtubules in the pathogenesis of early-onset familial Alzheimers diseaseR03AG060025 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BARTOLINI, FRANCESCA · 2018 to 2019
$162k
NIA NIH HHS R01 AG050658NIA NIH HHS R03 AG060025NIA NIH HHS R56 AG050658NINDS NIH HHS R21 NS120076
6 · The paper itself

Abstract

Microtubules (MTs) support a variety of neuronal functions, such as maintenance of cell structure, transport, and synaptic plasticity. Neuronal MTs are highly heterogeneous due to several tubulin isotypes and the presence of multiple post-translational modifications, such as detyrosination and acetylation. The tubulin tyrosination/detyrosination cycle is a key player in the maintenance of MT dynamics, as tyrosinated tubulin is associated with more dynamic MTs, while detyrosinated tubulin is linked to longer lived, more stable MTs. Dysfunction of tubulin re-tyrosination was recently correlated to Alzheimer's disease progression. The implication of tubulin acetylation in Alzheimer's disease has, however, remained controversial. Here, we demonstrate that tubulin acetylation accumulates in post-mortem brain tissues from Alzheimer's disease patients and human neurons harboring the Alzheimer's familial APP-V717I mutation. We further show that tubulin re-tyrosination, which is defective in Alzheimer's disease, can control acetylated tubulin in primary neurons irrespective of the levels of the enzymes regulating tubulin acetylation, suggesting that reduced MT dynamics associated with impaired tubulin re-tyrosination might contribute to the accumulation of tubulin acetylation that we detected in Alzheimer's disease.

Indexed as

acetylationAlzheimer’s diseasemicrotubuleneurontubulintubulin tyrosine ligasetyrosination

Identifiers

PMID36092705
PMCPMC9459041
OpenAlexW4293200026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.